M T11
Pill imprint M T11 has been identified as Topiramate 25 mg.
Topiramate is used in the treatment of migraine prevention; seizure prevention; bipolar disorder; smoking cessation; obesity (and more), and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy.
Topiramate 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Topiramate Images
- Imprint:
-
M T11
- Strength:
- 25 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide
crospovidone
hypromelloses
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
sodium lauryl sulfate
titanium dioxide
triacetin
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-6101
Advertisement
More Topiramate resources
- Topiramate (Wolters Kluwer)
- Topiramate Sprinkle Capsules (Wolters Kluwer)
- topiramate (Cerner Multum)
- topiramate (Micromedex) - Includes Dosage Information
- Topiramate (AHFS DI)
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate (Wolters Kluwer)
Search Again
